ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Chemical Works of Richter Gedeon PLC (PK)

Chemical Works of Richter Gedeon PLC (PK) (RGEDF)

27.1736
0.00
(0.00%)
Closed 09 December 8:00AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
27.1736
Bid
27.1736
Offer
27.1736
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
27.1736
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
185,946,210
Dividend Yield
605,564.84%
PE Ratio
0.03
Earnings Per Share (EPS)
854.28
Revenue
805.16B
Net Profit
158.85B

About Chemical Works of Richter Gedeon PLC (PK)

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Budapest, Hun
Founded
-
Chemical Works of Richter Gedeon PLC (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker RGEDF. The last closing price for Chemical Works of Richte... (PK) was US$27.17. Over the last year, Chemical Works of Richte... (PK) shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Chemical Works of Richte... (PK) currently has 185,946,210 shares in issue. The market capitalisation of Chemical Works of Richte... (PK) is US$5.05 billion. Chemical Works of Richte... (PK) has a price to earnings ratio (PE ratio) of 0.03.

RGEDF Latest News

Richter Signs Pact With Recordati for Marketing Cariprazine Drug

By Margit Feher BUDAPEST--Hungary's largest drug maker Richter Gedeon Nyrt. said on Tuesday that it has signed an exclusive license agreement with Italian drug firm Recordati for marketing...

Allergan's Uterine Fibroids Treatment Shows Efficacy

Allergan PLC and Gedeon Richter PLC on Monday said a late-stage study of ulipristal acetate in women with uterine fibroids met all of its endpoints. Shares rose 6.8% to $215.25 in midday trading...

CEE Morning Briefing: Hungary's MOL, Richter Earnings in Focus

By Margit Feher TODAY'S CALENDAR Local/GMT 0900/0700 Richter to hold briefing results 1330/1130 Hungary government weekly briefing 2400/2200 MOL 1Q earnings Hungarian oil and gas company...

European Medicines Agency Starts Valuation of Richter's Teriparatide

BUDAPEST--Hungarian drug maker Richter Gedeon Nyrt. (RICHTER.BU) said Monday that the European Medicines Agency had accepted Richter's regulatory submission for the proposed biosimilar to Eli...

Richter Net Profit Rises Amid Cost Cutting

BUDAPEST--Hungarian pharmaceuticals maker Richter Gedeon Nyrt. (RICHTER.BU) posted a larger-than-expected net profit for the first quarter as it substantially cut back sales and marketing costs...

Richter to Provide $5 Million Loan to Evestra for Drug Development

BUDAPEST--Pharmaceutical firm Richter Gedeon Nyrt., Hungary's largest home-grown drug maker signed a deal with US-based peer Evestra Inc on providing it with a $5 million convertible loan for drug...

Richter CEO: Expects Annual Revenue of EUR40 Million-EUR50 Million From Bayer Deal

By Veronika Gulyas BUDAPEST--Hungary-based drug maker Richter Gedeon Nyrt. (RICHTER.BU) expects annual revenues of up to 50 million euros over the next three to four years from the sales of Bayer...

Richter Signs License, Distribution Deal with Bayer HealthCare

By Veronika Gulyas BUDAPEST--Hungary-based central European pharmaceutical company Richter Gedeon Nyrt. (RICHTER.BU) said Tuesday that it has signed a license and distribution agreement with Bayer...

Richter Issues Profit Warning on Russian Ruble

By Veronika Gulyas BUDAPEST--Richter Gedeon Nyrt. (RICHTER.BU), Hungary's largest home-grown pharmaceutical firm, issued a profit warning on Tuesday after the Russian ruble weakened sharply...

European Business Hit By Russian Slowdown -- Update

By Noémie Bisserbe, Clemens Bomsdorf and Peter Evans A swath of European businesses, from banks to brewers, are taking big hits to their bottom lines caused by the political uncertainty...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PARNFParnell Pharmaceuticals Holdings Ltd (CE)
US$ 0.05
(4,999,900.00%)
20.19k
WPDPFWPD Pharmaceuticals Inc (PK)
US$ 0.001
(99,900.00%)
600
GXUSFGuardian Exploration Inc (QB)
US$ 0.0493
(49,200.00%)
3k
BYOCBeyond Commerce Inc (PK)
US$ 0.00014
(13,900.00%)
15.42M
WANSFCirata PLC (PK)
US$ 0.5261
(12,134.88%)
200
TEHGTechnovative Group Inc (CE)
US$ 0.000001
(-100.00%)
110
OOOOFOOOOO Entertainment Commerce Ltd (CE)
US$ 0.000001
(-99.99%)
11.5k
HAVLFHavn Life Sciences Inc (CE)
US$ 0.000001
(-99.98%)
667
PWWRFCleantech Power Corporation (CE)
US$ 0.000001
(-99.98%)
500
OFSIOmni Financial Services Inc (CE)
US$ 0.000001
(-99.78%)
500
HMBLHUMBL Inc (PK)
US$ 0.0023
(-11.54%)
1.53B
MJLBUltrack Systems Inc (PK)
US$ 0.0003
(100.00%)
612.64M
RDARRaadr Inc (PK)
US$ 0.002
(37.93%)
311.24M
GTCHGBT Technologies Inc (PK)
US$ 0.0001
(0.00%)
274.75M
NAFSNorth America Frac Sand Inc (PK)
US$ 0.0001
(-50.00%)
170.55M

Discussion

View Full Feed
floblu14 floblu14 1 minute ago
Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV)
Dec 09, 2024
PDF Version
Observed an antiviral effect for the primary and secondary virology endpoints i
ENTA
biocqr biocqr 2 minutes ago
News out? ENTA up 20%.
ENTA
Moonboy1 Moonboy1 4 minutes ago
What is this up so much? I don't see any news
GXAI
Streett Streett 5 minutes ago
Who owns the patent?  What we know for sure is that in the deal, if I have this right, HUMBL Pro is what remains in the HUMBL shell.  Everything else went to WSCG... correct?  The new company is bringing in a lot of product and if the SMX deal goes through, they will bring their own set of patents t
SMX
MasterBlastr MasterBlastr 6 minutes ago
I love Biden. He may not be a master politician, but he is a master of governing. He is setting things to run on autopilot while the Circus is in town.
Moonboy1 Moonboy1 7 minutes ago
All I know is I have shares and living it this morning
GXAI
dennisdave dennisdave 8 minutes ago
No one said they would look different "in the fall of this year". Innes said the company would like very different by THE END of this year.

Powers said this at last ASM:

It’s been longer than it was supposed to be (not shit), but all in all, I have to say, we’ve made, w
NWBO
TrendTrade2016 TrendTrade2016 11 minutes ago
ARE YOU STILL PRETENDING YOU ARE A WOMAN OR HAVE YOU COME OUT OF THE CLOSET MAGGOT
GVSI
ChannelTrader ChannelTrader 11 minutes ago
He's 49 today?...lol
MasterBlastr MasterBlastr 12 minutes ago
Short to zero, never cover. Free cash.
AMC
tapioca tapioca 17 minutes ago
How low will it go. R/S did nothing but screw shareholders yet again…
RNAZ
TJG TJG 19 minutes ago
That quote is what I wrote but what I should have said was "Notes were issued in 2020 and came due in Oct of 2024 they began converting"
"in Oct the 2020 notes were due and dilution started in Oct of 2024" TJG

I marvel at your assumptions and your ignorance of how this all fits
AFFU
nowwhat2 nowwhat2 23 minutes ago
T'was 2 weeks before XMas and all thru the house.......

https://investorshub.advfn.com/uimage/uploads/2024/12/9/dzfsqXRP_121212_9_2m_calvin_60_min_grinch.jpg


https://www.youtube.com/watch?v=v_qr45gQv6o


https://investorshub.advfn.com/uimage
XRPUSD
Konaploinks Konaploinks 25 minutes ago
Anyway. We’re up so far pre mkt. That’s a switch. Let’s hope it stays up.
IONQ
badog badog 26 minutes ago
ERHE Web Site back up, but

Who was it that said that ERHC was undoubtably remaking their website to give us new and updated positive material information?
How many times can speculators be wrong yet still claim to know what is coming. Well it looks like nothing is coming....
ERHE
Konaploinks Konaploinks 30 minutes ago
Yeah. But she is no dummy. She worked for Msft for 20 years then to Cisco? Then to Nvda for 7 years then quitting and coming to IonQ. Why did she skip over working for Nvda for 7 years in her last 2 presentations when introducing herself? I found that very odd. Also. I still can’t find any where on
IONQ
XMaster2023 XMaster2023 31 minutes ago
HyGro is being paid to lie. He knows it’s a lie but his objective is to mislead new investors so they believe the trial failed. Doc I know you know this but the new investors are trying to figure out if DCVax-L really works. My only advice is to read the JAMA Journal Article. It definitely works
NWBO
powerwalker powerwalker 32 minutes ago
Thank you, Guzzi, for posting this paywall SA article.
AVXL
sctts sctts 35 minutes ago
$$$ Today is the Day $$$$

$$$$ $FRX $$$$
FRX
Jack Torrance Jack Torrance 37 minutes ago
I can only assume they are waiting for some technical milestone to drop the advertising hammer of Thor, so to speak. Maybe they don't want to jump the gun if there are some unforeseen technical hurdles that come up? Again, I don't know. But I do think advertising is their weak link.

IONQ
gregcod gregcod 39 minutes ago
IBAT hired more than 4 new people with significant qualifications.the most recent hiree, Prairee engineer Don Bender, has me wondering what is coming up for IBAT..A good PR would provide more details im sure..and might get this stock to go over a buck or more quite soon.IMO.Im adding today again and
IBATF
ThunderousSeer8 ThunderousSeer8 39 minutes ago
This is the way
RDAR

Your Recent History

Delayed Upgrade Clock